Gene Bio Medical, attended the Canadian MedTech conference held in Toronto
Reaching new markets: Gene Bio Medical brings Canadian Innovation to the Indo-Pacific
Reaching new markets: Gene Bio Medical brings Canadian Innovation to the Indo-Pacific
Reaching new markets: Gene Bio Medical brings Canadian Innovation to the Indo-Pacific
Reaching new markets: Gene Bio Medical brings Canadian Innovation to the Indo-Pacific
Reaching new markets: Gene Bio Medical brings Canadian Innovation to the Indo-Pacific
It is with great pleasure that we announce Gene Biotechnology Enterprises Ltd as an executive commercialization partner of the CBRF PRAIRIE Hub, which is spearheaded by the University of Alberta, University of Calgary, and University of Saskatchewan/VIDO.
RSV is the leading cause of bronchiolitis—inflammation of the lung’s small airways. In infants, and the virus is so common that nearly all children have encountered it by their second birthday.
With three viruses at once, Canadian health officials have begun to warn that the new strains, BQ.1 and BQ.1.1, are spreading fast. “We are now seeing combinations of many viruses that are putting a lot of strain on the health care system.”
“They might be reluctant to be confirmed and be told not to go out at all,” says Catherine Smallwood, monkeypox incident manager at the World Health Organization’s (WHO’s) Regional Office for Europe. “We’re seeing a true decline,” Smallwood says.
Dr Anthony Fauci, America’s top infectious disease expert, has warned against prematurely declaring victory over the pandemic, not only due to short-term needs but because long Covid represents an “insidious” public health emergency for millions of people.
While the COVID-19 pandemic is now largely under control and public-health restrictions are eased in most countries, the unexpected outbreak of monkeypox has thwarted the people’s plan of returning to a normal life. As of mid-June 2022…